Your browser doesn't support javascript.
loading
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count.
Antinori, Andrea; Cicalini, Stefania; Meschi, Silvia; Bordoni, Veronica; Lorenzini, Patrizia; Vergori, Alessandra; Lanini, Simone; De Pascale, Lidya; Matusali, Giulia; Mariotti, Davide; Cozzi Lepri, Alessandro; Gallì, Paola; Pinnetti, Carmela; Gagliardini, Roberta; Mazzotta, Valentina; Mastrorosa, Ilaria; Grisetti, Susanna; Colavita, Francesca; Cimini, Eleonora; Grilli, Elisabetta; Bellagamba, Rita; Lapa, Daniele; Sacchi, Alessandra; Marani, Alessandra; Cerini, Carlo; Candela, Caterina; Fusto, Marisa; Puro, Vincenzo; Castilletti, Concetta; Agrati, Chiara; Girardi, Enrico; Vaia, Francesco.
Afiliación
  • Antinori A; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Cicalini S; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Meschi S; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Bordoni V; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Lorenzini P; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Vergori A; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Lanini S; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • De Pascale L; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Matusali G; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Mariotti D; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Cozzi Lepri A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College of London, London, United Kingdom.
  • Gallì P; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Pinnetti C; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Gagliardini R; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Mazzotta V; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Mastrorosa I; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Grisetti S; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Colavita F; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Cimini E; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Grilli E; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Bellagamba R; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Lapa D; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Sacchi A; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Marani A; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Cerini C; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Candela C; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Fusto M; Clinical Department, HIV/AIDS Unit, National Institute for Infectious Diseases Lazzaro Spallanzani Istituto di Ricovero e Cura a Carattere Scientifico, Roma, Italy.
  • Puro V; Risk Management, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Castilletti C; Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Agrati C; Laboratory of Cellular Immunology and Clinical Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Girardi E; Clinical Epidemiology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
  • Vaia F; Health Direction, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Roma, Italy.
Clin Infect Dis ; 75(1): e552-e563, 2022 08 24.
Article en En | MEDLINE | ID: mdl-35366316
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Infecciones por VIH / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas Virales / Infecciones por VIH / COVID-19 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Italia